Bicocca Open Archive

Logo unimib boa
MAGNI, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.563
EU - Europa 10.953
AS - Asia 4.012
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 13
AF - Africa 11
Totale 35.615
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.089
IT - Italia 2.577
DE - Germania 1.809
CN - Cina 1.628
SE - Svezia 1.602
IE - Irlanda 1.558
SG - Singapore 1.333
UA - Ucraina 815
RU - Federazione Russa 787
GB - Regno Unito 562
CA - Canada 459
HK - Hong Kong 445
AT - Austria 320
FI - Finlandia 245
FR - Francia 192
VN - Vietnam 182
IN - India 123
DK - Danimarca 121
NL - Olanda 96
ID - Indonesia 92
BE - Belgio 81
TR - Turchia 73
JP - Giappone 38
ES - Italia 27
CZ - Repubblica Ceca 26
PL - Polonia 25
BR - Brasile 24
IR - Iran 23
RO - Romania 21
EU - Europa 20
BG - Bulgaria 19
CH - Svizzera 16
KR - Corea 15
TW - Taiwan 14
GR - Grecia 13
MX - Messico 12
NO - Norvegia 11
AU - Australia 9
LT - Lituania 9
PH - Filippine 9
CL - Cile 6
IL - Israele 6
MY - Malesia 6
PT - Portogallo 6
TH - Thailandia 6
AR - Argentina 4
NZ - Nuova Zelanda 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
EC - Ecuador 3
LU - Lussemburgo 3
MT - Malta 3
PE - Perù 3
SA - Arabia Saudita 3
DZ - Algeria 2
HR - Croazia 2
MA - Marocco 2
MU - Mauritius 2
SC - Seychelles 2
SI - Slovenia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 35.615
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.346
Woodbridge 1.851
Fairfield 1.644
Chandler 1.520
Dublin 1.514
Houston 1.220
Singapore 1.118
Frankfurt am Main 1.094
Wilmington 1.013
Ashburn 1.000
Milan 921
Jacksonville 871
Dearborn 742
Seattle 670
Santa Clara 603
New York 584
Cambridge 549
Princeton 456
Hong Kong 431
Vienna 309
Shanghai 300
Nanjing 295
Altamura 181
Lawrence 175
Beijing 158
Lachine 143
Montréal 142
Dong Ket 127
Nanchang 115
Fremont 100
Jakarta 92
Helsinki 91
Guangzhou 85
Andover 77
San Diego 76
Brussels 73
Ottawa 71
Shenyang 70
Toronto 69
Hebei 66
London 60
Los Angeles 60
Boardman 59
Tianjin 50
Changsha 49
Lissone 45
Jiaxing 44
Jinan 41
Rome 41
Chicago 40
Falls Church 38
Huizen 37
Zhengzhou 37
Florence 36
Munich 36
Pune 35
Mountain View 34
Norwalk 34
Nürnberg 32
Caronno Pertusella 31
Ningbo 30
Kunming 28
Washington 28
Brescia 26
Monza 26
Auburn Hills 25
Cinisello Balsamo 24
Edmonton 23
Dallas 21
Brno 20
Pavia 20
Romola 20
Como 19
San Mateo 19
Detroit 18
Hangzhou 18
Kiev 18
Melzo 18
Bonndorf 17
Hefei 17
Plovdiv 17
Taizhou 17
Kilburn 16
Napoli 16
Sacramento 16
Sesto San Giovanni 16
University Park 16
Carate Brianza 15
Terni 15
Kocaeli 14
Madison 14
Padova 14
Ripalta Cremasca 14
Bergamo 12
San Giuliano Milanese 12
São Paulo 12
Turin 12
Cagliari 11
Centro Municipality 11
Naples 11
Totale 26.517
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 426
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 361
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 357
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 342
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 340
Differential protein profiling of renal cell carcinoma urinary exosomes 324
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 308
Urinary exosomes and diabetic nephropathy: a proteomic approach 298
MALDI imaging in Fabry nephropathy: a multicenter study 298
Urinary proteomics for the study of genetic kidney diseases 281
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 274
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 272
The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis 270
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 270
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 269
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 264
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 262
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 261
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 259
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 259
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 256
The proteomic landscape of renal tumors 249
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 247
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 245
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 239
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 239
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 238
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 236
The putative role of MALDI-MSI in the study of Membranous Nephropathy 234
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 234
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 233
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 232
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 231
Robust conclusions in mass spectrometry analysis 228
Mutual Information Optimization for Mass Spectra Data Alignment 227
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 227
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 223
Expression of heat shock protein 27 in human renal cell carcinoma 218
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 216
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 216
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 215
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 212
Proteomics for the diagnosis of thyroid lesions: Preliminary report 210
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 210
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 208
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 208
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 207
Proteomics for the study of new biomarkers in Fabry disease: State of the art 207
Tumor size, stage and grade alterations of urinary peptidome in RCC 205
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 204
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 201
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 200
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 198
Proteome analysis in thyroid pathology 196
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 195
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 193
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: Application to RCC urinary exosomes 193
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 191
Analysis of correlation structures in renal cell carcinoma patient data 187
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 184
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 183
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 182
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 182
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 180
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 179
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 179
1H NMR analysis of isocyclosporin A prepared in organic solvent and in aqueous solution 178
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 177
Diabetes-induced alteration of HMGCoA reductase forms in rat livers 174
Imaging mass spectrometry: a new tool for kidney disease investigations 174
HNE-Abeta adducts evaluated in vitro and in washed platelets by HPLC-ESI-MS 170
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 169
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 168
Proteomic knowledge of human aquaporins 168
Enzymatic synthesis of [methyl-2H3] creatinine 168
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 167
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 166
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 166
Differential expression of AQP1 in microdomain-enriched membranes of Renal Cell Carcinoma 165
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 164
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 163
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 163
1st National Congress of the Italian Proteome Society 162
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 162
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 160
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 159
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 158
Intraluminal proteome and peptidome of human urinary extracellular vesicles 158
Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae 156
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 156
A molecular imaging approach to individuate tumour infiltrating lymphocytes 155
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 154
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 154
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 153
Applying Random Graphs for Proteomic Data Analysis of RCC Patients 153
Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues 152
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 151
The continuous low dose insulin and glucose infusion test: a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies 150
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 150
Determination of plasma [6,6-2H2]glucose enrichment by a simple and accurate gas chromatographic-mass spectrometric method 150
Totale 21.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.752
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.493 0 0 0 0 0 734 892 423 560 346 390 148
2020/20215.044 282 242 520 592 447 406 535 462 387 468 260 443
2021/20223.272 261 295 307 415 200 267 119 192 156 244 282 534
2022/20236.033 670 1.860 485 603 352 860 72 375 380 62 183 131
2023/20244.723 138 155 192 320 515 1.359 988 125 295 76 121 439
2024/20253.695 470 925 594 457 898 351 0 0 0 0 0 0
Totale 36.855